| Title |
Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma
|
|---|---|
| Published in |
Drug Design, Development and Therapy, June 2014
|
| DOI | 10.2147/dddt.s31143 |
| Pubmed ID | |
| Authors |
Abhisek Swaika, Jennifer A Crozier, Richard W Joseph |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 2 | 1% |
| Unknown | 136 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 30 | 22% |
| Student > Ph. D. Student | 19 | 14% |
| Student > Master | 17 | 12% |
| Researcher | 16 | 12% |
| Student > Postgraduate | 8 | 6% |
| Other | 17 | 12% |
| Unknown | 31 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 34 | 25% |
| Medicine and Dentistry | 26 | 19% |
| Agricultural and Biological Sciences | 20 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Chemistry | 6 | 4% |
| Other | 10 | 7% |
| Unknown | 35 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2016.
All research outputs
#8,262,193
of 26,017,215 outputs
Outputs from Drug Design, Development and Therapy
#561
of 2,299 outputs
Outputs of similar age
#74,938
of 244,971 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 50 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,299 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,971 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.